Nachrichten zur Viking Therapeutics Inc. Aktie

Why This Weight Loss Drug Companys Stock Surged Today

Shares in biopharmaceutical company Viking Therapeutics (NASDAQ: VKTX) were up by 6.3% at 12:30 a.m. ET today. The move likely…

3 Growth Stocks Im Loading Up On

Growth stocks are having a moment. Several small- and mid-cap stocks have suddenly jumped 40% or more in the past…

My 5 Favorite Dirt Cheap Stocks to Buy Right Now

Though indexes have rebounded, the first half of the year has been rocky for investors. The market had to digest…

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

If youre looking to add growth to your portfolio, biotech stocks can be a great choice. Exciting research is happening…

Viking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should Know

In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $26.01, indicating a -1.03% shift from the previous…

Missed Out on Eli Lillys 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.

Eli Lilly (NYSE: LLY) has been one of the hottest healthcare stocks to own in recent years, thanks in large…

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

According to the average brokerage recommendation (ABR), one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly…

Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks?

When markets get jittery, high-growth stocks often take the biggest hits. But for investors with a stomach for volatility and…

Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note

The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $28.59, representing a -1.26% change from its previous close.…

1 Stock Down 34% This Year to Buy and Hold

Shares of Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech, are down by 34% this year. This poor performance may suggest…

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know

The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $26.61, representing a +1.88% change from its previous close.…

Could Viking Therapeutics Become the Next Eli Lilly?

The obesity treatment market is booming, with groundbreaking drugs like Eli Lillys (NYSE: LLY) Zepbound delivering transformative patient results and…

3 Best Growth Stocks to Buy in June

Growth investors have had to work harder than usual to find winners in 2025. With the S&P 500 essentially flat…

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Streets Bullish Views?

The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall…

Viking Therapeutics: Obesity Candidates Must Prove Their Edge As Market Matures (Upgrade)

…

Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?

With VKTX surging on clinical results and NVO investing to cement market share, investors face a high-stake GLP-1 showdown.…

Better Weight Loss Stock: Amgen or Viking Therapeutics?

Investors looking to cash in on the fast-growing market for weight management medicines will naturally turn to the two leaders…

Viking Therapeutics: Weight-Loss Story Remains Intact

…

Viking Therapeutics: A High Potential Biotech Play With Manageable Risks

…

Why Viking Therapeutics Stock Bumped 3% Higher Today

A major C-suite change at a potential competitor was a key factor behind the rise of Viking Therapeutics (NASDAQ: VKTX)…

Why Weight-Loss Developer Stocks Tumbled on Tuesday

Makers of weight-loss drugs, the hottest segment of the pharmaceutical market just now, werent looking so hot on the stock…

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years

Investing in promising companies before their stock prices soar is an excellent recipe for earning life-changing returns. However, with hundreds…

3 Monster Stocks in the Making

Think of some of the biggest and most successful stocks on the market. Now, go back 20 or 30 years.…

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April

One of the best catalysts for a stocks rise is the withdrawal of a rival. That was an important dynamic…

Why Viking Therapeutics Stock Was Victorious This Week

Viking Therapeutics (NASDAQ: VKTX), a biotech that has shot to prominence thanks to a weight-loss drug it is developing, was…

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

GLP-1 drug prices are falling. Thats good news for patients, but perhaps not such good news for pharmaceutical stock investors.…

Is Novo Nordisk Stock a Buy?

For years, Denmark-based Novo Nordisk (NYSE: NVO) was a fairly traditional develop-and-market pharmaceutical company that escaped notice by many investors.…

1 Beaten-Down Stock to Buy and Hold for 10 Years

Viking Therapeutics (NASDAQ: VKTX) was one of the hottest biotech stocks of 2024; its shares soared last year following excellent…

Why Viking Therapeutics Stock Popped Today

2025 is the year we learn whether Viking Therapeutics stock will be a winner.…

Think Its Too Late to Buy Novo Nordisk? Heres the Biggest Reason Why Theres Still Time.

Almost unarguably, the most significant story in our time with the pharmaceutical industry is the emergence and sharp rise of…

Did Eli Lilly Just Say Checkmate to Novo Nordisk?

Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around…

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $23.94, representing a +1.44% change from its previous close.…

2 Stocks Down by 25% or More This Year to Buy and Hold

Equity markets have had a rough go of it this year due to President Trumps macroeconomic policies. Though it can…

Viking Therapeutics: A Lot More Compelling After The Meltdown - Initiating Cautious Buy (Rating Upgrade)

…

Viking Therapeutics: Trading The Volatility Of The Weight Loss Drug Market

…

Viking Therapeutics VK2735 Candidate Likely Boosted By Pfizers Woes

…

Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?

No one ever claimed investing in the biotech industry was a smooth ride, but for shareholders of Viking Therapeutics (NASDAQ:…

3 Magnificent Stocks That Could Double or More by 2030

When the stock market is as turbulent as it is these days, its easy to forget the times when things…

Viking Therapeutics Aktie: VK2735 als Hoffnungsträger mit modernem Wirkansatz

New York (www.aktiencheck.de) - Viking Therapeutics-Aktienanalyse von Goldman Sachs: Richard Law, Analyst von Goldman Sachs, nimmt die Coverage der Aktie von…

The Smartest Biotech Stocks to Buy With $50

One of the great things about equity markets is that you dont need a fortune to get started. Though strong…

Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade

In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $23.91, marking a -0.99% move from the previous day.…

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall…

Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know

In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $29.28, indicating a +1.14% shift from the previous…

Motley Fool 2025 March Market Cap Showdown Championship

It all comes down to this...the final round of the Motley Fool Rule Breaker Investing March Market Cap Showdown! Defending…

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

Its hard to overstate how much demand could be out there for effective weight management drugs. The global anti-obesity drug…

Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?

Viking Therapeutics (NASDAQ: VKTX) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may eventually…

Why Novo Nordisk Stock Outpaced the Market on Tuesday

Novo Nordisk (NYSE: NVO), the Danish company best known as the maker of weight loss drug Wegovy, expanded a little…

An Ozempic successor falls short, Eli Lillys GLP-1 pill, and senators grill RFK: Pharma news roundup

Plus, Eli Lillys CEO got a pay raise, and Viking Therapeutics gets closer to bringing its Ozempic competitor to market…

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $29.73, denoting a +0.61% change from…

Viking Therapeutics: No Buyout Needed Now

…